chr10-29291854-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_StrongBP6_Moderate
The ENST00000375500.8(LYZL1):c.125G>A(p.Arg42Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000744 in 147,884 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
ENST00000375500.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LYZL1 | NM_032517.6 | c.-14G>A | 5_prime_UTR_variant | 2/5 | ENST00000649382.2 | ||
LYZL1 | XM_005252627.4 | c.125G>A | p.Arg42Gln | missense_variant | 2/5 | ||
LYZL1 | XM_017016791.2 | c.125G>A | p.Arg42Gln | missense_variant | 2/5 | ||
LYZL1 | XR_428650.2 | n.173G>A | non_coding_transcript_exon_variant | 2/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LYZL1 | ENST00000375500.8 | c.125G>A | p.Arg42Gln | missense_variant | 2/5 | 1 | |||
LYZL1 | ENST00000649382.2 | c.-14G>A | 5_prime_UTR_variant | 2/5 | NM_032517.6 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000744 AC: 11AN: 147768Hom.: 0 Cov.: 24
GnomAD3 exomes AF: 0.000128 AC: 27AN: 210816Hom.: 0 AF XY: 0.000125 AC XY: 14AN XY: 112384
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.000225 AC: 317AN: 1411418Hom.: 2 Cov.: 34 AF XY: 0.000213 AC XY: 149AN XY: 698346
GnomAD4 genome AF: 0.0000744 AC: 11AN: 147884Hom.: 0 Cov.: 24 AF XY: 0.0000693 AC XY: 5AN XY: 72134
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 29, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at